Iconocast Logo

Welcome To Iconocast

How to add a URL link from your web site to the Iconocast web sites

Virtual tour of Southern California



 

Recent News and Articles on the Keywords: melanoma + diagnosis + dermatologists  Related to the article below (Last Update: 8/5/2008)

2 faces of skin doctors - medical, cosmetic Beauty patients on A ...
San Francisco Chronicle,  USA - Aug 3, 2008
A few months later, Ryan said, she sought a second opinion from another dermatologist, whose diagnosis was melanoma. "I don't know if dermatology, ...
Skin cancer: 'Neil was a fighter - we thought he would survive'
Independent, UK -
The doctor explained the diagnosis was stage three melanoma, with a six in 10 chance of survival. "Dr Harries called it an evil cancer because it's so ...
Electro-Optical Sciences Completes Patient Accrual in MelaFind(R ...
CNNMoney.com -
MelaFind is a non-invasive, point-of-care instrument designed and developed by EOS to assist in the early diagnosis of melanoma, the deadliest form of skin ...MELA
New Weapon in War on Skin Cancer
RedOrbit, TX -
"An experienced GP will be able to give a diagnosis straight away and if in any doubt at all will refer on to a dermatologist." In the 10 years between 1996 ...
McCain Candidacy Raises Melanoma Profile
RedOrbit, TX - Jul 30, 2008
Early diagnosis and treatment are key to surviving melanoma, the experts said. The society estimated that 8420 Americans will die this year from melanoma. ...

Los Angeles Times
McCain needs frequent checks for skin cancer
Los Angeles Times, CA - Jul 28, 2008
The American Cancer Society has more information on melanoma diagnosis and treatment. Photo credit: AP/Eric Draper. This photo was taken of McCain after a ...
McCain Has Growth Removed From Face
WebMD - Jul 28, 2008
While McCain was previously treated for melanoma, a top skin cancer expert, talking in general based on the information available, says it is unlikely the ...
New Research on Genetic Changes in Melanomas and Teens' Use of ...
MarketWatch - Jul 30, 2008
At the American Academy of Dermatology's Summer Academy Meeting 2008 in Chicago, dermatologist Martin A. Weinstock, MD, PhD, FAAD, professor of dermatology ...
Skin cancer risks are plain as day, but who's listening?
Fall River Herald News,  USA -
The journal Archives of Dermatology published a study of beachgoers between the ages of 18 and 30 that showed while 87 percent understood the link between ...
Mayor gets dunked for melanoma fundraiser
Norwich Bulletin, CT - Aug 2, 2008
Education and better screening and diagnosis techniques helps increase the chances of survival, said Corrine Renaldi, 50, of Norwich, a friend of the ...
Source: Google News

Increase in the sensitivity for melanoma diagnosis by primary care physicians using skin surface … -
K Westerhoff, WH Mccarthy, SW Menzies - British Journal of Dermatology, 2000 - Blackwell Synergy
... in the USA, the score for correct diagnosis was 60% (six of 37 lesions were melanoma). ...
4 An evaluation among dermatologists at the University Department of ...

Clinical accuracy of the diagnosis of cutaneous malignant melanoma -
CA Morton, RM MacKie - Br J Dermatol, 1998 - Mass Med Soc
... A histopathologic diagnosis of melanoma was made for 128 lesions, of which 113 were
correctly diagnosed before surgery. Dermatologists with more than 10 years ...

… , is the most reliable method for teaching dermoscopy for melanoma diagnosis to residents in … -
P Carli, E Quercioli, S Sestini, M Stante, L Ricci … - British Journal of Dermatology, 2003 - Blackwell Synergy
... Pattern analysis, not simplified algorithms, is the most reliable method for teaching
dermoscopy for melanoma diagnosis to residents in dermatology. ... melanoma. ...

Is Dermoscopy (Epiluminescence Microscopy) Useful for the Diagnosis of Melanoma? Results of a Meta- … -
ML Bafounta, A Beauchet, P Aegerter, P Saiag - Archives of Dermatology, 2001 - Am Med Assoc
... Three investigators, 2 dermatologists (M.-LB and PS ... the diagnostic performance of
dermoscopy on melanoma was compared ... of dermoscopy, accuracy of diagnosis of a ...

Epiluminescence Microscopy for the Diagnosis of Doubtful Melanocytic Skin Lesions Comparison of the … -
G Argenziano, G Fabbrocini, P Carli, V De Giorgi, … - Archives of Dermatology, 1998 - Am Med Assoc
... and diagnostic accuracy for melanoma were calculated for the overall ELM diagnosis
of the ... ELM diagnoses of experienced and less experienced dermatologists. ...

Optimization of the ABCD Formula Used for Melanoma Diagnosis
A Alvarez, S Bajcar, FM Brown, JW Grzymala-Busse, … - Intelligent Information Processing and Web Mining: …, 2003 - books.google.com
... on melanoma were collected at the Regional Dermatology Cen -ter in Rzeszow, Poland
[9]. The data consisted of 410 cases. In diagnosis of melanoma an important ...

Discordance in the histopathologic diagnosis of melanoma and melanocytic nevi between expert … -
ER Farmer, R Gonin, MP Hanna - Human Pathology, 1996 - Elsevier
... Miller M, Ackerman AB: How accurate are dermatologists in the diagnosis of melanoma?
Degree of accuracy and implications. Arch Dermatol 128:559-560, 1992 22. ...

Melanoma Diagnosis by Raman Spectroscopy and Neural Networks: Structure Alterations in Proteins and … -
M Gniadecka, PA Philipsen, S Sigurdsson, S Wessel, … - Journal of Investigative Dermatology, 2004 - nature.com
... & Olkin I. A comparison of dermatologists' and primary ... physician accuracy in diagnosing
melanoma: A systemic ... & Kokkanikis G. Computer aided diagnosis of breast ...

A multiple classifier system for early melanoma diagnosis -
A Sboner, C Eccher, E Blanzieri, P Bauer, M … - Artificial Intelligence In Medicine, 2003 - Elsevier
... However, specific training of dermatologists for melanoma diagnosis takes time and
resources [3]. On the other hand, specifically trained dermatologists face ...

How accurate are dermatologists in the diagnosis of melanoma? Degree of accuracy and implications.
M Miller, AB Ackerman - Arch Dermatol, 1992 - ncbi.nlm.nih.gov
... 1992 Sep;128(9):1278. How accurate are dermatologists in the diagnosis of melanoma?
Degree of accuracy and implications. Miller M, Ackerman AB. ...

Source: Google Scholar
 

Dermatologists Warn Myths About Melanoma Could Lead to Delayed Diagnosis and Treatment

When it comes to melanoma – the most serious form of skin cancer that accounts for more than 75 percent of skin cancer deaths – knowing the facts about its causes and characteristics could save your life. Dermatologists hope that dispelling some common myths about melanoma could help more people understand their risk factors and be more aware of melanomas that don’t fit the typical diagnostic mold.

“Despite our ongoing public education efforts on the causes and symptoms of melanoma, a number of misconceptions about this potentially deadly disease exist,” said dermatologist Diane R. Baker, MD, FAAD, president of the American Academy of Dermatology (Academy). “These myths could cause some people to think they are not at risk for melanoma because of their skin type or to dismiss warning signs because they are not typical symptoms of the disease.”

Article continues below and (thank you)

 

Myth: All melanomas follow the ABCD rule.
Fact: When the ABCD rule for early melanoma diagnosis was designed more than 20 years ago, it offered a tool for physicians to aid in distinguishing potentially cancerous lesions from benign pigmented moles. The ABCD acronym stands for Asymmetry (meaning one half of the mole is different from the other), Border Irregularity (the edges or borders of melanomas are usually ragged or notched), Color (melanoma often has a variety of hues and colors within the same lesion), and Diameter (most melanomas are usually greater than 6 mm in diameter when diagnosed, although they can be smaller).

However, like all rules, there are bound to be exceptions. Numerous studies show that not all melanomas follow the ABCD rule. One study published in the May 2003 issue of the Journal of the American Academy of Dermatology (JAAD) examined a specific type of melanoma known as nodular melanoma (NM) that does not fit the ABCD criteria for melanoma diagnosis. NMs commonly occur as symmetric, elevated lesions that are uniform in color and non-pigmented.

“When most people think of melanoma, they often associate a black- or brown-colored lesion or a mole that changes colors,” said Dr. Baker. “This study demonstrates that nodular melanomas lack a change in color, with 71 percent of the NM patients participating in the study reporting no noticeable change in color versus 57 percent of patients classified with the more traditional ‘superficial spreading melanoma’ that noted a color change in their lesions. This is one example where NM patients relied more on the changing nature of their suspicious lesions – primarily bleeding and catching on clothing – than the ABCD characteristics.”

Another study, published in the December 8, 2004, issue of the Journal of the American Medical Association, supports the argument that not all melanomas follow the ABCD rule – noting data which demonstrated the smaller size (less than 6 mm) and the “evolving” nature of some melanomas, including changes in size, shape and symptoms (commonly involving itching, bleeding or tenderness).

Myth: Moles that have hairs are not cancerous.
Fact: Although the vast majority of melanocytic (or pigmented) moles with hairs are benign, a new study published in the March 2007 issue of JAAD references three cases where the presence of one or more hairs in a pigmented lesion proved to be invasive melanoma. The authors of the study stress that a melanoma diagnosis should not be automatically ruled out in cases of pigmented lesions simply because they contain hair, and patients should closely monitor all moles for signs of skin cancer – regardless of whether or not hair is present.

“As the study investigators mention, one possible explanation as to why this myth originated is that when melanoma was commonly diagnosed in more advanced stages many years ago – marked by larger and thicker lesions – it would subsequently destroy the surrounding hair follicles,” noted Dr. Baker. “Today, dermatologists are diagnosing melanomas much earlier, when the lesions are thinner and before hair follicles are wiped out. This study clearly illustrates that melanoma can defy the odds in terms of diagnosis and all suspicious lesions should be evaluated without exception.”

Myth: People of color don’t get skin cancer.
Fact: While Caucasians are 10 times more likely to be diagnosed with melanoma than other races, studies show that African-Americans are more likely to develop the condition on non-sun-exposed areas of the body – such as the nails, soles of the feet, palms of the hands, mouth, nasal passages and genitals. One study showed that while 90 percent of Caucasian patients develop melanoma on skin that is regularly sun-exposed, only 33 percent of African-American patients developed the condition in these areas.

“The common belief that melanoma and other skin cancers don’t affect people of color goes hand-in-hand with the myth that skin cancers only develop in sun-exposed areas,” explained Dr. Baker. “In fact, these ‘hidden’ melanomas are extremely dangerous, because they don’t always follow the ABCD rule for melanoma detection, their symptoms can mimic other medical conditions, and they are not easily detected. People of color, like all patients, need to heed the Academy’s recommendation to conduct regular skin self-examinations and learn how to spot the warning signs of hidden melanomas.”

Experts stress that when diagnosed, melanoma in skin of color patients has often spread to other parts of the body. A study published in the January 2004 issue of JAAD compared the stage of initial melanoma diagnosis of African-American patients versus Caucasian patients and their respective prognoses. Of the 649 patients studied, 32.1 percent of African-American patients were diagnosed with stage III or stage IV melanoma, as compared to only 12.7 percent of Caucasian patients. When melanoma progresses to these advanced stages, it is usually fatal.

“The common thread running through all these myths is that when it comes to melanoma, patients and dermatologists alike need to think outside the box,” added Dr. Baker. “Patients need to be vigilant in monitoring their skin for any changes that could signal a problem, and dermatologists play a pivotal role in diagnosing melanoma at its earliest and most treatable stage.”

One American dies of melanoma almost every hour (every 65 minutes). In 2007, 8,110 deaths will be attributed to melanoma – 5,220 men and 2,890 women. The five-year survival rate for people whose melanoma is detected and treated before it spreads is 99 percent.

May 7 is Melanoma Monday® and the official launch of Melanoma/Skin Cancer Detection and Prevention Month®. For more information about skin cancer, please visit www.skincarephysicians.com and click on “SkinCancerNet.”

The American Academy of Dermatology (Academy), founded in 1938, is the largest, most influential, and most representative of all dermatologic associations. With a membership of more than 15,000 physicians worldwide, the Academy is committed to: advancing the diagnosis and medical, surgical and cosmetic treatment of the skin, hair and nails; advocating high standards in clinical practice, education, and research in dermatology; and supporting and enhancing patient care for a lifetime of healthier skin, hair and nails. For more information, contact the Academy at 1-888-462-DERM (3376) or http://www.aad.org.

 

Internet Unborn Baby Gender Test Draws Fire

A test being sold on the Internet allowing future parents to know the gender of their unborn child has come in for criticism.

BBC News reports the procedure uses the pregnant woman's blood obtained from a pin prick and detects whether it has a "Y" chromosome. This would mean the baby would be a boy.

The company marketing the test, DNA Worldwide, claims it is 99 percent accurate and offers a refund if the prediction turns out to be wrong, BBC News reports. The test can be done after six weeks of pregnancy.

It is not new science, the BBC says, but many organizations are concerned that commercial marketing of it could lead to abuse. A number of British anti-abortion groups are opposing the test, fearing that if prospective parents find out that the sex of their unborn baby is not the one they want, they would seek an abortion.

And at least one UK medical group opposes the test. A spokesman for the Royal College of Obstetricians and Gynaecologists told the BBC that gender selection under these circumstances is inappropriate. "Focus should remain firmly on the health and care of the mother and developing baby, rather than gender," the BBC quotes a spokesman as saying.

David Nicholson, the director of DNA Worldwide, rejected these concerns, telling BBC News that surveys of those who have used the service in the past year didn't indicate that an increase in abortions was occurring.

-----

Autistic Children Miss Visual Cues in Facial Expressions, Study Finds

Children with autism can't "read" the subtleties of expression in a person's face, a new UCLA study has concluded.

The study, being presented over the weekend at the International Meeting for Autism Research in Seattle, used functional magnetic resonance imaging (fMRI), on two groups of children -- 16 high-functioning individuals with autism and 16 typically developing children. According to a UCLA news release, both groups were shown images of faces with different expressions: anger, fear, happiness, and neutrality.

After monitoring the children's brain activity through the fMRI, the scientists found that the autistic children registered virtually no activity in the part of the brain that recognizes differences in people's expressions.

"They don't pick up what's going on -- they miss the nuances, the body language and facial expressions and sometimes miss the big picture and instead focus on minor, less socially relevant details," said Mari Davies, a UCLA graduate student in psychology who was a co-leader in the research. "That, in turn, affects interpersonal bonds."

-----

20 Million Chickens Kept Off U.S Market Pending Inspection of Feed

About 20 million chickens won't be heading to market next week after federal officials placed them on hold Friday because their feed contained an industrial chemical.

According to the Associated Press, the chickens may still go to market, but a weekend risk assessment needed to be made first. This includes: the absence of melamine (the chemical in question) in feed used by the larger chicken producers; whether the pet food has been diluted with larger amounts of other ingredients in the feed; how healthy the chickens are that ate the feed; no evidence that the trace amounts of melamine would harm humans.

The wire service says officials from the U.S. Department of Agriculture, the Environmental Protection Agency, and the U.S. Food and Drug Administration are overseeing the risk assessment in wake of millions of units of pet food being recalled during the past two months because of the presence of melamine.

Melamine, which was introduced in a gluten additive from China, is believed to have been the agent that caused the deaths of thousands of dogs and cats, primarily from liver failure.

The names of the producers whose chickens were in question weren't announced Friday, but the A.P. said that the 20 million fowl in question was a small fraction of the 9 billion chickens consumed in the United States every year. Nevertheless, USDA spokesperson Keith Wlliams is quoted by the wire service as saying, "Absent the risk assessment in this particular situation, USDA will not put the seal of inspection on this meat."

-----

FDA Issues Guidelines to Test for Antifreeze Substance Sometimes Found in Cough Syrup

The lethal combination of a sweetener used in many cough medicines with an antifreeze chemical has prompted the U.S. Food and Drug Administration (FDA) to issue what it calls a "guidance" to medical professionals, drug companies, suppliers and drug repackers.

While emphasizing that the agency has received no new reports of deaths because glycerin and diethylene glycol (DEG) were found in medicications such as cough syrup, the FDA Friday issued guidelines for testing to see if these two substances are combined in any pharmaceutical products. DEG, a solvent, has been associated with many accidental deaths.

Last September, more than 40 people in Panama died because of DEG-contimated glycerin in cough syrup, the FDA says, and a similar incident occurred in Haiti in late 1995-1996, when 80 children died because of the same lethal combination in cough syrup.

-----

Feeling Useful Boosts Older Adults' Physical Ability

Feeling useful appears to improve older adults' physical functioning, according to a U.S. study to be presented Friday at the annual scientific meeting of the American Geriatrics Society.

Researchers analyzed data on more than 900 people, ages 70 to 79. They found that feeling useful led to improvements in "performance-based" physical functioning, which includes coordination, balance, gait, and upper and lower limb strength.

The participants underwent physical performance tests and were asked about their feelings of usefulness at the start of the study and again three years later. The study was conducted by researchers at Kirksville College of Osteopathic Medicine in Missouri and the University of California, Los Angeles Medical School.

"Compared to older adults who frequently felt useful to others (at the start of the study), those who never or rarely did had greater declines in physical performance ability," the study authors wrote. "However, increases in feelings of usefulness were also associated with an improvement in physical performance."

Previous research found that older adults with low feelings of usefulness are more likely to suffer declines in physical ability and to die over a seven-year-period.

-----

High-Dose Radiotherapy Benefits Prostate Cancer Patients

Compared with standard-dose radiotherapy, high-dose radiotherapy lowers the risk of cancer recurrence and reduces the need for additional hormone treatment in prostate cancer patients, says a U.K. study published online in The Lancet medical journal.

"However, the higher radiation dose did slightly increase bowel side effects," chief investigator David Dearnaley of the Institute of Cancer Research and Royal Marsden Hospitals in Sutton, said in a prepared statement.

The study included 843 prostate cancer patients who received either a standard dose of radiotherapy (64 Gy) or a higher dose (74 Gy).

Dearnaley said "the dose increase was made possible by using a new more precise radiation treatment method called conformal radiotherapy."

He noted that the "trial is important in emphasizing the advantage of higher dose radiotherapy but also the need to continue to improve radiation techniques."

 
Google
Web www.iconocast.com
 
 
Continue News With: News7 ; News8 ; News9 ; News9A


ADVERTISEMENT

Iconocast is about learning and teaching without borders; we offer eMarketing, Internet Advertising, Internet Marketing, Search Engine Optimization, Search Engine Marketing, Online Branding, and eMarketing News Services.

 

Iconocast Home Page

 © 2002-2006

Keywords:

Contact Iconocast